Search Finnegan

Our Insights

7 results

Webinar

Trends in Pharmaceutical Patents and the Potential Impact of Exclusivity Trends in Pharmaceutical Patents and the Potential Impact of Exclusivity

November 17, 2020

Webinar

Conference

FDA Boot Camp FDA Boot Camp

September 23-24, 2020

Virtual

Articles

FDA Amends Regulations for 505(b)(2) Applications and ANDAs—Part II FDA Amends Regulations for 505(b)(2) Applications and ANDAs—Part II

October 2017

Intellectual Property & Technology Law Journal

Articles

FDA Amends Regulations for 505(b)(2) Applications and ANDAs—Part I FDA Amends Regulations for 505(b)(2) Applications and ANDAs—Part I

September 2017

Intellectual Property & Technology Law Journal

Articles

How 21st Century Cures Act Affects Combination Products How 21st Century Cures Act Affects Combination Products

June 20, 2017

Law360

Articles

Dead Zone: Are Your Biological Products Ready for FDA's Regulatory Transition? Dead Zone: Are Your Biological Products Ready for FDA's Regulatory Transition?

April 2017

American Pharmaceutical Review

Articles

FDA Amends Regulations for 505(b)(2) Applications and ANDAs FDA Amends Regulations for 505(b)(2) Applications and ANDAs

November 29, 2016

FDA Flash! Blog